Publication: 2925

A prognostic model integrating clinical information and gene expression signatures in phase III neoadjuvant trial CALGB 40601(Alliance).
   Google Scholar   
Citation:
Ann Oncol vol 29 (suppl_7) abstr SPS-3
Meeting Instance:
JSMO 2018
Year:
2018
Type:
Abstract
Sub type:
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
Yes
Biospecimen:
No
SDC:
No
Parents:
None
Children:
2809  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U24CA196171  
Corr. Author:
 
Authors:
                           
Networks:
LAPS-CT018, LAPS-MA036, LAPS-NC007, LAPS-NY016   
Study
CALGB-40601
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: